PubRank

B Lioure

Author PubWeight™ 32.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001 1.71
2 Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant 2000 1.44
3 Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Br J Haematol 1997 1.33
4 Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant 2009 1.28
5 Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). Blood 1997 1.26
6 Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de Moelle. Blood 1996 1.23
7 Candida catenulata fungemia in a cancer patient. J Clin Microbiol 1999 1.17
8 Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Br J Haematol 2000 1.13
9 Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol 2000 1.12
10 Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. J Clin Oncol 2000 0.99
11 Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. J Infect 2006 0.97
12 Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study. Transplantation 1995 0.92
13 Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation. Bone Marrow Transplant 2012 0.89
14 A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). Blood 1998 0.88
15 Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial. Leukemia 2010 0.87
16 First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party. Bone Marrow Transplant 2004 0.87
17 Molecular analysis of rearranged VH genes during B cell chronic lymphocytic leukemia: intraclonal stability is frequent but not constant. Leuk Lymphoma 1994 0.86
18 ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts. Leukemia 2004 0.86
19 Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. Br J Haematol 1998 0.84
20 Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. Clin Chem 2000 0.82
21 [Auto-immune-like disease post-bone marrow transplantation]. Rev Med Interne 2004 0.82
22 Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation. Br J Haematol 1997 0.80
23 Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype. Leukemia 2006 0.80
24 Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment. Bone Marrow Transplant 2009 0.80
25 A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia. Leukemia 2005 0.80
26 [Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation]. Agressologie 1992 0.80
27 Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study. Hum Gene Ther 1997 0.79
28 Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS. Adv Exp Med Biol 1999 0.78
29 Severe abdominal pain and inappropriate antidiuretic hormone secretion preceding varicella-zoster virus reactivation 10 months after autologous stem cell transplantation for acute myeloid leukaemia. Bone Marrow Transplant 2005 0.78
30 Resection of mycotic lung sequestra after invasive aspergillosis. Ann Thorac Surg 1993 0.77
31 Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995 0.76
32 Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT. Bone Marrow Transplant 2011 0.76
33 Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry. Bone Marrow Transplant 1998 0.75
34 Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). Bone Marrow Transplant 1997 0.75
35 Varicella in immunocompromised patients. Lancet 2006 0.75
36 Unusual cytogenetic evolution in CML treated with interferon-alpha. Leukemia 1997 0.75
37 Hearing loss due to acute leukemia. Am J Med 2000 0.75
38 IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity? Bone Marrow Transplant 1991 0.75
39 [Two French masters with a "Red-Skin" bed-head]. Rev Med Interne 2004 0.75
40 [Muscular metastases disclosing adenocarcinoma]. Rev Med Interne 1997 0.75
41 Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia. Cancer Genet Cytogenet 1999 0.75
42 Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients. Bone Marrow Transplant 1995 0.75
43 Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma. Leuk Lymphoma 1996 0.75
44 Evaluation of residual masses after lymphoma treatment: the contribution of gallium 67 tomoscintigraphy. Nouv Rev Fr Hematol 1990 0.75
45 Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment. Transplantation 1991 0.75
46 High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002 0.75
47 [Failure of bone marrow autograft in metastatic malignant adrenalcortical carcinoma]. Ann Endocrinol (Paris) 2000 0.75
48 Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam Group. Br J Haematol 1996 0.75
49 Molecular analysis of T-cell receptor V beta chains of human T-cell chronic lymphocytic leukemia does not show intraclonal variability: implications for immunotherapy. Blood 1993 0.75
50 Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease. Ann Oncol 1997 0.75
51 A new DR14 allele (DRB1*1411) containing a short DR11 sequence and its haplotypic association. Hum Immunol 1993 0.75
52 [Hodgkin's disease with vertebral localizations. Indication for orthopedic treatment]. Presse Med 1993 0.75
53 [Veno-occlusive disease of the liver and POEMS syndrome]. Presse Med 1999 0.75
54 [Invasive aspergillosis in immunocompromised patients. An analysis of 57 patients]. Agressologie 1992 0.75
55 High dose chemotherapy in ovarian cancer. Int J Gynecol Cancer 2001 0.75
56 [Carboplatin and cyclophosphamide in stage Ic-IV ovarian carcinoma: retrospective study of 101 cases]. Bull Cancer 1996 0.75
57 Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data. Ann Hematol 2004 0.75
58 Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use. Bone Marrow Transplant 1996 0.75
59 [Occurrence of severe, persistent thrombocytopenia following allogeneic bone marrow transplantation, attributable to anti-HPA-1 allo-immunisation of the host]. Transfus Clin Biol 2010 0.75
60 [A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies]. Pathol Biol (Paris) 2006 0.75